Effect of yoga as add-on therapy in migraine (CONTAIN)
A randomized clinical trial
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 31, 2019
- Accepted in final form November 22, 2019
- First Published May 6, 2020.
Article Versions
- Previous version (May 6, 2020 - 13:04).
- You are viewing the most recent version of this article.
Author Disclosures
- Anand Kumar, MD, DM,
- Rohit Bhatia, MD, DM, DNB,
- Gautam Sharma, MD, DM,
- Dhanlika Dhanlika, BSc,
- Sreenivas Vishnubhatla, PhD,
- Rajesh Kumar Singh, MD, DM,
- Deepa Dash, MD, DM,
- Manjari Tripathi, DM and
- M.V. Padma Srivastava, DM
- Anand Kumar, MD, DM,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rohit Bhatia, MD, DM, DNB,
NONE
NONE
NONE
Associate Editor of Journal of Stroke Medicine, 2018 to current. This is the official journal of Indian Stroke Association.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gautam Sharma, MD, DM,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Dhanlika Dhanlika, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sreenivas Vishnubhatla, PhD,
NONE
NONE
NONE
Statistical Section Editor for Indian Journal of Dermatology, Venereology & Leprosy Editorial Board memeber of Napalese Journal of Statistics
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rajesh Kumar Singh, MD, DM,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Deepa Dash, MD, DM,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Manjari Tripathi, DM and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- M.V. Padma Srivastava, DM
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (A.K., R.B.), Department of Cardiology (G.S.), Centre for Integrated Medicine and Research (CIMR) (D.D.), and Department of Biostatistics (S.V.), All India Institute of Medical Sciences (R.K.S., D.D., M.T., M.V.P.S.); and Cardio-thoracic Centre (G.S.), New Delhi, India.
- Correspondence
Dr. Bhatia rohitbhatia71{at}yahoo.com
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Erenumab in chronic migrainePatient-reported outcomes in a randomized double-blind studyRichard B. Lipton, Stewart J. Tepper, Uwe Reuter et al.Neurology, April 17, 2019 -
Articles
An international study to assess reliability of the Migraine Disability Assessment (MIDAS) scoreW.F. Stewart, R.B. Lipton, J. Whyte et al.Neurology, September 01, 1999 -
Article
Erenumab (AMG 334) in episodic migraineInterim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J. Goadsby et al.Neurology, August 23, 2017 -
Articles
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disabilityWalter F. Stewart, Richard B. Lipton, Andrew J. Dowson et al.Neurology, March 01, 2001